Skip to Main Content

Paper Details

Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma.
Cancers (Basel)
11
2021
PD-1, PD-L1, Patient, RCC, RNA, Renal Cell Carcinoma, T cell, T cell receptor, T effector, TCR, advanced RCC, circulating lymphocytes, circulating neutrophils, clear, clear cell signatures, gene expression signatures, myeloid inflammation, patient, patients, renal cell carcinoma
Author NameAffiliation
Anupama Reddy
Benjamin G VincentLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Benjamin G VincentUniversity of North Carolina at Chapel Hill
Benjamin G VincentUniversity of North Carolina at Chapel Hill
Wendy Kimryn RathmellVanderbilt University Medical Center
  • 1 - 5

Datasets

Release 1.2